[1]刘雪艳 刘利娟 童海婷.重型颅脑损伤血清Caspase-3的水平变化及其意义[J].中国临床神经外科杂志,2020,(04):215-217.[doi:10.13798/j.issn.1009-153X.2020.04.008]
 LIU Xue-yan,LIU Li-juan,TONG Hai-ting..Change of serum level of Caspase-3 and its clinical meanings in patients with severe traumatic brain injury[J].,2020,(04):215-217.[doi:10.13798/j.issn.1009-153X.2020.04.008]
点击复制

重型颅脑损伤血清Caspase-3的水平变化及其意义()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年04期
页码:
215-217
栏目:
论著
出版日期:
2020-04-30

文章信息/Info

Title:
Change of serum level of Caspase-3 and its clinical meanings in patients with severe traumatic brain injury
文章编号:
1009-153X(2020)04-0215-03
作者:
刘雪艳 刘利娟 童海婷
723000 陕西,汉中三二〇一医院神经外科(刘雪艳);723000 陕西,汉中市中心医院神经外科(刘利娟、童海婷)
Author(s):
LIU Xue-yan1 LIU Li-juan2 TONG Hai-ting2.
1. Department of Neurosurgery, 3201 Hospital, Hanzhong 723000, China; 2. Department of Neurosurgery, Hanzhong Central Hospital, Hanzhong 723000, China
关键词:
重型颅脑损伤血清Caspase-3预后
Keywords:
Severe traumatic brain injury Serum Caspase-3 Prognosis
分类号:
R 651.1+5; Q 786
DOI:
10.13798/j.issn.1009-153X.2020.04.008
文献标志码:
A
摘要:
目的 探讨重型颅脑损伤(TBI)病人入院血清天冬氨酸半胱氨酸特异性蛋白酶-3 (Caspase-3)水平变化及临床意义。方法 选取2016年6月~2019年6月收治的重型TBI病人120例,另选取性别、年龄相匹配的健康体检者120例为对照。根据伤后30 d内存活情况将TBI病人分为存活组(n=91)和死亡组(n=29)。采用酶联免疫吸附试验法检测入院血清Caspase-3水平。结果 重型TBI组血清Caspase-3水平明显高于对照组(P<0.05)。死亡组血清Caspase-3水平明显高于存活组(P<0.05)。重型TBI病人入院血清Caspase-3浓度与入院GCS评分呈负相关,与入院Marshall CT分级和血清C-反应蛋白(CRP)呈正关(P<0.05)。多因素logistic回归分析显示入院GCS评分3~5分、入院Marshall CT分级Ⅴ~Ⅵ级、入院血清CRP >20 mg/L、入院血清Caspase-3>548 ng/ml是重型TBI病人伤后30d内死亡的独立危险因素(P<0.05)。ROC曲线分析结果显示入院血清Caspase-3预测重型TBI病人伤后30 d内死亡的最佳临界值为423 ng/ml,曲线下面积为0.862,灵敏度为85.69%、特异度为64.50%。结论 重型TBI病人入院血清Caspase-3水平显著升高,对预测病人伤后30 d内死亡有一定价值。
Abstract:
Objective To investigate the change of serum level of aspartate cysteine specific protease-3 (Caspase-3) in patients with severe traumatic brain injury (TBI) and its clinical significances. Methods The serum levels of Caspase-3 in 120 patients with severe TBI who were admitted from June 2016 to June 2019 (TBI) and 120 healthy patients with matching gender and age (control group) were measured by enzyme-linked immunosorbent assay. Of 120 severe TBI patients, 91 patients survived (survival group) and 29 died (death group) within 30 days after injury. Results The serum level of Caspase-3 in the TBI group was significantly higher than that in the control group (P<0.05). The serum level of Caspase-3 in the death group was significantly higher than that in the survival group (P<0.05). The serum level of Caspase-3 in patients with severe TBI was significantly negatively correlated with the admission GCS score, and significantly positively correlated with admission Marshall CT classification and serum C-reactive protein (CRP) level (P<0.05). Multivariate logistic regression analysis showed that the admission GCS score of 3~5, the admission Marshall CT grade Ⅴ~Ⅵ, the admission serum CRP level >20 mg/L, and the admission serum level of Caspase-3 >548 ng/ml were independent risk factors for the death of severe TBI patients within 30 days after injury (P<0.05). The results of ROC curve analysis showed that the optimal cut-off value of serum level of Caspase-3 was 423 ng/ml for predicting the death of severe TBI patients within 30 days after injury, with a sensitivity of 85.69% and a specificity of 64.50%. Conclusion The serum level of Caspase-3 in patients with severe TBI is significantly increased, which is of certain value for predicting the patients' death within 30 days after injury.

参考文献/References:

[1] Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets [J]. Front Cell Neurosci, 2019, 13: 528-539.
[2] Wang ZF, Gao C, Chen W, et al. Salubrinal offers neuropro- tection through suppressing endoplasmic reticulum stress, autophagy and apoptosis in a mouse traumatic brain injury model [J]. Neurobiol Learn Mem, 2019, 161: 12-25.
[3] 廖宝共,卢 非,张 献,等. 脉血康对缺血性脑卒中的疗 效及对LPA、Caspase-3水平的影响[J]. 中华中医药学刊, 2018,36(11):2720-2722.
[4] Sun DB, Xu MJ, Chen QM, et al. Significant elevation of serum caspase-3 levels in patients with intracerebral hemorrhage [J]. Clin Chim Acta, 2017, 471: 62-67.
[5] 肖 萌,金保哲,张岱男. 微透析技术在创伤性颅脑损伤 临床治疗与基础研究中的应用[J]. 中华神经外科杂志, 2018,34(7):748-751.
[6] Wang KK, Yang Z, Zhu T, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury [J]. Expert Rev Mol Diagn, 2018, 18(2): 165-180.
[7] Charry JD, Navarro-Parra S, Solano J, et al. Outcomes of traumatic brain injury: the prognostic accuracy of various scores and models [J]. Neurol Neurochir Pol, 2019, 53(1): 55-60.
[8] Naghibi T, Mohajeri M, Dobakhti F. Inflammation and out- come in traumatic brain injury: does gender effect on survi- val and prognosis [J]. J Clin Diagn Res, 2017, 11(2): Pc06- pc09.
[9] Lorente L, Martin MM, Abreu-Gonzalez P, et al. Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients [J]. BMC Res Notes, 2019, 12(1): 789.
[10] Zhang ZY, Li J, Ye Q, et al. Usefulness of serum interleu- kin-33 as a prognostic marker of severe traumatic brain injury [J]. Clin Chim Acta, 2019, 497: 6-12.
[11] Gan ZS, Stein SC, Swanson R, et al. Blood biomarkers for traumatic brain injury: a quantitative assessment of diagnostic and prognostic accuracy [J]. Front Neurol, 2019, 10: 446.

相似文献/References:

[1]陈 彬 陈治标 刘 佳.早期同时行脑室-腹腔分流术+颅骨修补术治疗 重型颅脑损伤的疗效[J].中国临床神经外科杂志,2016,(05):304.[doi:10.13798/j.issn.1009-153X.2016.05.017]
[2]刘 军 袁辉纯 徐立新.体温控制对重型颅脑损伤血肿清除术后的疗效及血清IMA、MDA的影响[J].中国临床神经外科杂志,2016,(07):412.[doi:10.13798/j.issn.1009-153X.2016.07.008]
 LIU Jun,YUAN Hui-chun,XU Li-xin.Effects of body temperature on serum levels of ischemia-modified albumin and malondialdehyde after surgery for intracranial hematomas in patients with severe traumatic brain injury[J].,2016,(04):412.[doi:10.13798/j.issn.1009-153X.2016.07.008]
[3]郭宏伟 高玉松 罗新名 张松坡 胡承啸 扈俊华 柴 超 雷亚萍.重型颅脑损伤继发脑梗死的早期防治[J].中国临床神经外科杂志,2016,(07):416.[doi:10.13798/j.issn.1009-153X.2016.07.009]
 GUO Hong-wei,GAO Yu-song,LUO Xin-ming,et al.Treatment of delayed cerebral infarction after severe craniocerebral injury[J].,2016,(04):416.[doi:10.13798/j.issn.1009-153X.2016.07.009]
[4]宋晓阳 黎笔熙 陈 敏 甘国胜 秦明哲 程鹏飞 陶 军 周 翔.血栓弹力图在重型颅脑损伤患者围手术期的应用[J].中国临床神经外科杂志,2016,(01):17.[doi:10.13798/j.issn.1009-153X.2016.01.006]
 SONG Xiao-Yang,LI Bi-Xi,CHEN Min,et al.Application of thrombelastography to guiding perioperative treatment of patients with severe traumatic brain injury[J].,2016,(04):17.[doi:10.13798/j.issn.1009-153X.2016.01.006]
[5]郭宏伟 高玉松 罗新民 扈俊华 尹一恒 张松坡 胡承啸.重型颅脑损伤继发应激性胃粘膜病变的危险因素分析[J].中国临床神经外科杂志,2015,(06):368.[doi:10.13798/j.issn.1009-153X.2015.06.018]
[6]任志文 赵 冬 刘 祺 王 惠 王业忠.亚低温对重型颅脑损伤患者血清MMP-9、颅内压和脑血流动力学的影响[J].中国临床神经外科杂志,2015,(07):398.[doi:10.13798/j.issn.1009-153X.2015.07.005]
 REN Zhi-wen,ZHAO Dong,LIU Qi,et al.Effect of mild hypothermia on serum level of MMP-9, intracranial pressure and cerebral blood flow dynamics in patients with severe craniocerebral injury[J].,2015,(04):398.[doi:10.13798/j.issn.1009-153X.2015.07.005]
[7]刘福增 王 鹏 韩树生 殷尚炯 张建宇.改良T形切口去骨瓣减压术治疗重型颅脑损伤的疗效观察[J].中国临床神经外科杂志,2015,(07):424.[doi:10.13798/j.issn.1009-153X.2015.07.014]
[8]高玉松 扈俊华 罗新名 张亚东 郭宏伟 张松坡 胡承啸 雷亚平.咪达唑仑对重型颅脑损伤患者应激性胃黏膜病变的影响[J].中国临床神经外科杂志,2015,(07):426.[doi:10.13798/j.issn.1009-153X.2015.07.015]
[9]曹 轲 段兴浩 刘玉飞 冯 进 徐兴国 陈一笑 马 辉 李宗正.重型颅脑损伤去骨板减压术后早期腰椎穿刺术与继发性脑积水的关系[J].中国临床神经外科杂志,2015,(09):535.[doi:10.13798/j.issn.1009-153X.2015.09.008]
 CAO Ke,DUAN Xing-hao,LIU Yu-fei,et al.Analysis of relationship between early lumbar puncture and the incidence of secondary postoperative hydrocephalus in patients with severe traumatic brain injury[J].,2015,(04):535.[doi:10.13798/j.issn.1009-153X.2015.09.008]
[10]周 杰 何光祥 陈玉秋 酉 建 刘洛同 明 扬 陈礼刚.重型颅脑损伤术后无创脑水肿监测的临床应用[J].中国临床神经外科杂志,2015,(03):144.[doi:10.13798/j.issn.1009-153X.2015.03.005]
 ZHOU Jie,He Guang-xiang,CHEN Yu-qiu,et al.Non-invasive monitoring of postoperative cerebral edema in patients with severe craniocerebral trauma[J].,2015,(04):144.[doi:10.13798/j.issn.1009-153X.2015.03.005]
[11]李建军.血清NSE与颅脑损伤术后早期颅内压增高-累计时间的相关性[J].中国临床神经外科杂志,2018,(02):78.
 LI Jian-jun..Correlativity of serum level of neuron specific enolase with pressure times time dose of intracranial pressure in patients with severe traumatic brain injury[J].,2018,(04):78.

备注/Memo

备注/Memo:
(2020-01-15收稿,2020-04-17修回)
更新日期/Last Update: 2020-04-10